As of 2024-12-10, the Relative Valuation of Lexicon Pharmaceuticals Inc (LXRX) is (16.82) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.74 USD, the upside of Lexicon Pharmaceuticals Inc based on Relative Valuation is -2385.2%.
The range of the Relative Valuation is (17.13) - (19.00) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.6x - 45.5x | 35.3x |
| Forward P/E multiples | 20.1x - 31.7x | 20.9x |
| Fair Price | (17.13) - (19.00) | (16.82) |
| Upside | -2427.4% - -2681.2% | -2385.2% |
| Date | P/E |
| 2024-11-29 | -1.34 |
| 2024-11-27 | -1.34 |
| 2024-11-26 | -1.37 |
| 2024-11-25 | -1.36 |
| 2024-11-22 | -1.44 |
| 2024-11-21 | -1.29 |
| 2024-11-20 | -1.35 |
| 2024-11-19 | -1.47 |
| 2024-11-18 | -1.51 |
| 2024-11-15 | -1.63 |
| 2024-11-14 | -1.77 |
| 2024-11-13 | -1.82 |
| 2024-11-12 | -1.99 |
| 2024-11-11 | -2.12 |
| 2024-11-08 | -2.12 |
| 2024-11-07 | -2.17 |
| 2024-11-06 | -2.02 |
| 2024-11-05 | -1.99 |
| 2024-11-04 | -2.01 |
| 2024-11-01 | -2.04 |
| 2024-10-30 | -3.26 |
| 2024-10-29 | -3.39 |
| 2024-10-28 | -3.11 |
| 2024-10-25 | -3.01 |
| 2024-10-24 | -3.07 |
| 2024-10-23 | -3.11 |
| 2024-10-22 | -3.24 |
| 2024-10-21 | -3.26 |
| 2024-10-18 | -3.47 |
| 2024-10-17 | -3.36 |
| 2024-10-16 | -3.19 |
| 2024-10-15 | -2.99 |
| 2024-10-14 | -2.99 |
| 2024-10-11 | -2.91 |
| 2024-10-10 | -2.82 |
| 2024-10-09 | -2.72 |
| 2024-10-08 | -2.81 |
| 2024-10-07 | -2.81 |
| 2024-10-04 | -2.82 |
| 2024-10-03 | -2.69 |
| 2024-10-02 | -2.69 |
| 2024-10-01 | -2.64 |
| 2024-09-30 | -2.62 |
| 2024-09-27 | -2.67 |
| 2024-09-26 | -2.57 |
| 2024-09-25 | -2.52 |
| 2024-09-24 | -2.62 |
| 2024-09-23 | -2.64 |
| 2024-09-20 | -2.77 |
| 2024-09-19 | -2.82 |